McKesson Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $419.95
- Today's High:
- $424.81
- Open Price:
- $423
- 52W Low:
- $330.7966
- 52W High:
- $440.3515
- Prev. Close:
- $423.9
- Volume:
- 480700
Company Statistics
- Market Cap.:
- $56.90 billion
- Book Value:
- -11.875
- Revenue TTM:
- $284.04 billion
- Operating Margin TTM:
- 1.6%
- Gross Profit TTM:
- $12.36 billion
- Profit Margin:
- 1.32%
- Return on Assets TTM:
- 4.49%
- Return on Equity TTM:
- 0%
Company Profile
McKesson Corporation had its IPO on 1994-11-15 under the ticker symbol MCK.
The company operates in the Healthcare sector and Medical Distribution industry. McKesson Corporation has a staff strength of 45,000 employees.
Stock update
Shares of McKesson Corporation opened at $423 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $419.95 - $424.81, and closed at $422.1.
This is a -0.42% slip from the previous day's closing price.
A total volume of 480,700 shares were traded at the close of the day’s session.
In the last one week, shares of McKesson Corporation have increased by +2.37%.
McKesson Corporation's Key Ratios
McKesson Corporation has a market cap of $56.90 billion, indicating a price to book ratio of 5.0435 and a price to sales ratio of 0.192.
In the last 12-months McKesson Corporation’s revenue was $284.04 billion with a gross profit of $12.36 billion and an EBITDA of $5.06 billion. The EBITDA ratio measures McKesson Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, McKesson Corporation’s operating margin was 1.6% while its return on assets stood at 4.49% with a return of equity of 0%.
In Q2, McKesson Corporation’s quarterly earnings growth was a positive 33.4% while revenue growth was a positive 10.9%.
McKesson Corporation’s PE and PEG Ratio
- Forward PE
- 14.245
- Trailing PE
- 15.7386
- PEG
- 0.6173
Its diluted EPS in the last 12-months stands at $26.8 per share while it has a forward price to earnings multiple of 14.245 and a PEG multiple of 0.6173. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into McKesson Corporation’s profitability.
McKesson Corporation stock is trading at a EV to sales ratio of 0.2099 and a EV to EBITDA ratio of 14.2575. Its price to sales ratio in the trailing 12-months stood at 0.192.
McKesson Corporation stock pays annual dividends of $2.16 per share, indicating a yield of 0.59% and a payout ratio of 8.17%.
Balance sheet and cash flow metrics
- Total Assets
- $64.10 billion
- Total Liabilities
- $48.42 billion
- Operating Cash Flow
- $-149000000.00
- Capital Expenditure
- $124 million
- Dividend Payout Ratio
- 8.17%
McKesson Corporation ended 2024 with $64.10 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $64.10 billion while shareholder equity stood at $-1602000000.00.
McKesson Corporation ended 2024 with $1.14 billion in deferred long-term liabilities, $48.42 billion in other current liabilities, 3000000.00 in common stock, $13.18 billion in retained earnings and $9.97 billion in goodwill. Its cash balance stood at $2.64 billion and cash and short-term investments were $2.64 billion. The company’s total short-term debt was $350,000,000 while long-term debt stood at $5.61 billion.
McKesson Corporation’s total current assets stands at $45.54 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $21.86 billion compared to accounts payable of $43.98 billion and inventory worth $20.51 billion.
In 2024, McKesson Corporation's operating cash flow was $-149000000.00 while its capital expenditure stood at $124 million.
Comparatively, McKesson Corporation paid $0.08 in dividends in 2024.
Other key metrics
- Current Trading Price
- $422.1
- 52-Week High
- $440.3515
- 52-Week Low
- $330.7966
- Analyst Target Price
- $472.86
McKesson Corporation stock is currently trading at $422.1 per share. It touched a 52-week high of $440.3515 and a 52-week low of $440.3515. Analysts tracking the stock have a 12-month average target price of $472.86.
Its 50-day moving average was $417.54 and 200-day moving average was $383.78 The short ratio stood at 1.98 indicating a short percent outstanding of 0%.
Around 15.2% of the company’s stock are held by insiders while 8767.9% are held by institutions.
Frequently Asked Questions About McKesson Corporation
Similar Industry Stocks (Medical Distribution)
Most Active
Top Gainers
Top Losers
About
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.